Brolucizumab coming?

anonymous

Guest
This product will plummet aflibercept sales some what? Data for it looks good, is Eylea in more trouble that people think? I know renting specialists are looking for a more durable molecule and brolucizumab might be it. Projections are that Eylea is going to have it's lunch eaten.
 






This product will plummet aflibercept sales some what? Data for it looks good, is Eylea in more trouble that people think? I know renting specialists are looking for a more durable molecule and brolucizumab might be it. Projections are that Eylea is going to have it's lunch eaten.

Must be a Lucentis troll writing this. Clearly can’t spell or proofread. Go back to your corner